Breast Cancer Clinical Trial

Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection

Summary

The researchers are doing this study to see if having immediate lymphatic reconstruction after axillary lymph node dissection (ALND) can decrease the development of lymphedema, a side effect of ALND. Other purposes of the study include:

Comparing the approach of immediate lymphatic reconstruction after ALND with the approach of ALND alone Looking at whether having immediate lymphatic reconstruction after ALND improves a person's quality of life Seeing if adding standard of care radiation therapy to either study approach (immediate lymphatic reconstruction after ALND or ALND alone) has an effect on development of lymphedema

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female breast cancer patients 18-75 years of age
Patients consenting for unilateral ALND (prior history of SLNBx allowed if <6 months from consent) OR patients consenting for unilateral SLNBx with possible ALND, with a clinically or radiographically positive lymph node OR a high likelihood of ALND per the Breast Surgeon
Identification of at least one transected lymphatic channel and at least one vein to be used for bypass at the time of ALND during surgery

Exclusion Criteria:

Male breast cancer patients
Non-English speaking participants
Female breast cancer patients with axillary recurrence
Female breast cancer patients who have a history of ALND
Female patients requiring bilateral ALND for the treatment of their breast cancer
Female breast patients treated with SLNBx only

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

174

Study ID:

NCT04241341

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (Consent and Followup)
Basking Ridge New Jersey, 07920, United States More Info
Michelle Coriddi, MD
Contact
646-608-8042
Memorial Sloan Kettering Monmouth (Consent Only)
Middletown New Jersey, 07748, United States More Info
Michelle Coriddi, MD
Contact
646-608-8042
Memorial Sloan Kettering Bergen (Consent Only)
Montvale New Jersey, 07645, United States More Info
Michelle Coriddi, MD
Contact
646-608-8042
Memorial Sloan Kettering Commack (Consent only)
Commack New York, 11725, United States More Info
Michelle Coriddi, MD
Contact
646-608-8042
Memorial Sloan Kettering Westchester (Consent Only)
Harrison New York, 10604, United States More Info
Michelle Coriddi, MD
Contact
646-608-8042
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
Michelle Coriddi, MD
Contact
646-608-8042
Memorial Sloan Kettering Nassau (Consent only)
Uniondale New York, 11553, United States More Info
Michelle Coriddi, MD
Contact
646-608-8042

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

174

Study ID:

NCT04241341

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider